Over the past few years, COVID-19 has overshadowed seasonal respiratory diseases like respiratory syncytial virus infection. But this year, early surges in RSV across the United States have spurred public attention. Though the infection is a common cause of respiratory disease, it is often overlooked in adults, said Michael Melgar, MD, a medical officer with the Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases.
While we can't predict how soon we may see a vaccine on the market, it is a really good sign that there are multiple products underway by different manufacturers, all of which are being studied at the same time. It's a promising time for RSV prevention.There's nothing conclusive that can be said. RSV, and other respiratory viruses as well, really declined during the first couple years of the COVID-19 pandemic.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »